Accessibility Tools

15,909 views 61 media
https://www.cdc.gov/coronavirus/2019-ncov/index.html
Media type
1:4:04
Moderna @ SXSW 2024: Disrupting Cancer Care for the Whole Patient
32 views Featured
Kyle Holen, Moderna’s Head of Development, Therapeutics and Oncology, moderated...
Media type
27:51
Moderna @ CES 2024: The Future of Medicine - Individualized Treatments
27 views Featured
Our President Stephen Hoge joined American College of Cardiology's Dr. Ami Bhatt...
Media type
54:14
Moderna @ SXSW 2024: Why We Should Be Talking About Quantum
23 views Featured
Moderna’s Wade Davis, VP, Computational Science, joined Heather Higgins, Partner...
Media type
0:34
Through COVAX we can fairly distribute vaccines to all countries
22 views Featured
With vaccines now rolling out, protection against the COVID-19 virus is spreadin...
Media type
0:16
COVID-19 vaccines - Pandemica series: Hands
26 views Featured
Join our fight for #VaccineEquity at www.who.int/vaccinequity This is what coron...
Media type
0:31
COVID-19 vaccines - Pandemica series: Destination vaccination
29 views Featured
Join our fight for #VaccineEquity at www.who.int/vaccinequity We can’t afford fo...

Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.